血脂康与阿托伐他汀联合治疗高血压合并冠心病的临床分析

Clinical Analysis on Xuezhikang Combined With Atorvastatin in Treatment of Hypertension Complicated with Coronary Heart Disease

目的对血脂康与阿托伐他汀联合治疗高血压合并冠心病的临床效果进行分析与探讨。方法从2014年10月-2015年10月我院所收治的高血压合并冠心病患者中选取60例参与研究,分为对照组和实验组,对照组患者采用阿托伐他汀治疗,实验组患者采用血脂康联合阿托伐他汀治疗,观察治疗效果,进行对比分析。结果实验组的治疗总有效率优于对照组,组间差异具有统计学意义（P〈0.05）。结论对于患有高血压合并冠心病的患者,采用血脂康联合阿托伐他汀治疗法具有疗效。

Objective Analysis and investigation on clinical effect of xuezhikang combined with atorvastatin in treatment of hypertension complicated by coronary heart disease. Methods Chose 60 patients with hypertension complicated by coronary heart disease who were treated in hospital from October 2014 to October 2015,to study and separated them into control group and study group respectively. Patients in control group were given atorvastatin treatment only,while,other patients in study group were given xuezhikang combined with atorvastatin treatment,and then observe and make a comparative analysis on treatment effects between two groups. Results Patients＇ treatment efficacy in study group is much more favorable than that in control group,and such a differential has statistic value（P〈0.05）. Conclusion Patients with hypertension complicated by coronary heart disease,xuezhikang combined with atorvastatin treatment is quite effective and satisfactory.